FDA Recall Terminated

Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2

Recall: Z-1274-2021 · Initiated February 8, 2021

Recall

Recall Number
Z-1274-2021
Event Number
87381
Firm
Siemens Healthcare Diagnostics, Inc
FEI Number
1219913
Product Code
MYF
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
February 8, 2021
Posted
March 18, 2021
Terminated
February 7, 2025
Address
333 Coney St, East Walpole, MA, 02032-1516

Description

Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2

Reason

Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System.

Action

In February 2021, Siemens will issue an Urgent Medical Device Correction notice to customers via letter stating that Siemens Healthcare Diagnostics Inc. has confirmed that the ADVIA Centaur HSV2 assay does not meet the 60 day onboard stability or the 28 day calibration frequency (interval) as stated in the ADVIA Centaur XP/XPT Herpes-2 IgG (HSV2).

Distribution

Domestic: AL, CA, FL, IL, MD, NJ, NY, TN, TX. Foreign: Nepal, Chile, Georgia, Spain.

Quantity

390 kits total (Domestic 366 kits, Foreign 24 kits)